Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov .
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov .

Dr. Shree Ram Singh

Dr. Shree Ram Singh

Scientific Review Officer



Biography

Division:
Division of Translational and Clinical Sciences DTCS
Review Branch:
Cancer Diagnosis, Prevention & Therapeutics CDPT

Dr. Shree Ram Singh received his Ph.D. in genetics from the Banaras Hindu University, India, and was a scientist at Goethe University Frankfurt, Germany. After postdoctoral training at Haifa University, Israel, and at the National Cancer Institute (NCI), he became a staff scientist at NCI. He has performed research in the broader area of cancer biology, stem cell biology, cell signaling, genetics, genomics, cancer metabolism, anti-tumor immunity, tumor microenvironment, and anti-cancer drug discovery. Dr. Singh has published 9 books and over 150 research articles in prestigious journals such as Nature, Cell Stem Cell, Developmental Cell, Nature Communications, Oncogene, Cancer Letters, and Cell Reports. Prior to joining CSR, he was a scientific review officer at NCI. He has several years of experience in managing the peer review process of a large breadth of funding mechanisms in the broader area of cancer research involving multi-project and single-project cooperative agreements, research training grants, clinical trials, and initiatives for basic, clinical, and translational research. 

 

Last updated: 09/24/2025 05:05